The Food and Drug Administration (FDA) is launching a new program to ramp up the United States’s domestic pharmaceutical ...

Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...

Because price and margin headwinds exist predominantly in small-molecule oral tablets that are easy to produce, we expect Viatris’ pipeline to focus more on complex generics—drugs that have complex ...

Discover groundbreaking research from Harvard Medical School revealing lithium's critical role in brain health, aging and ...

On June 30, 2025, FDA’s Human Foods Program published its proposed 2025 guidance agenda, including the Agency’s priority ...

The Food and Drug Administration Aug. 7 announced a new program to help improve the domestic pharmaceutical supply chain by ...

Presbyopia is a common variant of farsightedness affecting over 128 million people in the US, including the majority of ...

The initiative is a response to a Trump administration order to speed the construction of the type of new drug factories many pharmaceutical companies have promised to build.

An ongoing outbreak of Salmonella in Canada is linked to pistachios, including those found in Dubai chocolate. Health ...

A new program to boost U.S. drug manufacturing with streamlined processes, regulatory support. Read more here.

Lilly's weight-loss medications Mounjaro and Zepbound are gaining market share on Novo's Wegovy and Ozempic, but investors ...